Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 382035, 6 pages
http://dx.doi.org/10.1155/2014/382035
Research Article

Adiponectin Ameliorates Endotoxin-Induced Acute Cardiac Injury

1Department of Vascular Surgery, Cardiology, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan
2Department of Cardiology, Nagoya University Graduate School of Medicine, 65 Tsurumai, Showa, Nagoya 466-8550, Japan
3Molecular Cardiovascular Medicine, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan

Received 17 June 2014; Accepted 21 July 2014; Published 10 August 2014

Academic Editor: Carlos Dieguez

Copyright © 2014 Yoshio Watanabe et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. C. Angus and R. S. Wax, “Epidemiology of sepsis: an update,” Critical Care Medicine, vol. 29, no. 7, pp. S109–S116, 2001. View at Publisher · View at Google Scholar · View at Scopus
  2. A. F. Suffredini, R. E. Fromm, M. M. Parker et al., “The cardiovascular response of normal humans to the administration of endotoxin,” The New England Journal of Medicine, vol. 321, no. 5, pp. 280–287, 1989. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Kumar, C. Haery, and J. E. Parrillo, “Myocardial dysfunction in septic shock, Part I: clinical manifestation of cardiovascular dysfunction,” Journal of Cardiothoracic and Vascular Anesthesia, vol. 15, no. 3, pp. 364–376, 2001. View at Publisher · View at Google Scholar · View at Scopus
  4. J. E. Parrillo, M. M. Parker, C. Natanson et al., “Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy,” Annals of Internal Medicine, vol. 113, no. 3, pp. 227–242, 1990. View at Publisher · View at Google Scholar · View at Scopus
  5. C. Natanson, P. W. Eichenholz, R. L. Danner et al., “Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock,” Journal of Experimental Medicine, vol. 169, no. 3, pp. 823–832, 1989. View at Publisher · View at Google Scholar · View at Scopus
  6. T. Peng, X. Lu, M. Lei, G. W. Moe, and Q. Feng, “Inhibition of p38 MAPK decreases myocardial TNF-alpha expression and improves myocardial function and survival in endotoxemia,” Cardiovascular Research, vol. 59, no. 4, pp. 893–900, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. T. Peng, X. Lu, and Q. Feng, “Pivotal role of gp91phox-containing NADH oxidase in lipopolysaccharide-induced tumor necrosis factor-α expression and myocardial depression,” Circulation, vol. 111, no. 13, pp. 1637–1644, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. A. El-Solh, P. Sikka, E. Bozkanat, W. Jaafar, and J. Davies, “Morbid obesity in the medical ICU,” Chest, vol. 120, no. 6, pp. 1989–1997, 2001. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Yaegashi, R. Jean, M. Zuriqat, S. Noack, and P. Homel, “Outcome of morbid obesity in the intensive care unit,” Journal of Intensive Care Medicine, vol. 20, no. 3, pp. 147–154, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. M. B. Bailey, D. L. Davenport, L. Procter, S. McKenzie, and H. D. Vargas, “Morbid obesity and diverticulitis: results from the ACS NSQIP dataset,” Journal of the American College of Surgeons, vol. 217, pp. 874–880.e1, 2013. View at Google Scholar
  11. R. S. Ahima, “Adipose tissue as an endocrine organ,” Obesity, vol. 14, supplement 5, pp. 242S–249S, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. C. J. Lyon, R. E. Law, and W. A. Hsueh, “Minireview: adiposity, inflammation, and atherogenesis,” Endocrinology, vol. 144, no. 6, pp. 2195–2200, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. V. Vachharajani and D. N. Granger, “Adipose tissue: a motor for the inflammation associated with obesity,” IUBMB Life, vol. 61, no. 4, pp. 424–430, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. N. Ouchi, J. L. Parker, J. J. Lugus, and K. Walsh, “Adipokines in inflammation and metabolic disease,” Nature Reviews Immunology, vol. 11, no. 2, pp. 85–97, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. K. Ohashi, R. Shibata, T. Murohara, and N. Ouchi, “Role of anti-inflammatory adipokines in obesity-related diseases,” Trends in Endocrinology and Metabolism, vol. 25, no. 7, pp. 348–355, 2014. View at Google Scholar
  16. R. Shibata, N. Ouchi, and T. Murohara, “Adiponectin and cardiovascular disease,” Circulation Journal, vol. 73, no. 4, pp. 608–614, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. R. Shibata, T. Murohara, and N. Ouchi, “Protective role of adiponectin in cardiovascular disease,” Current Medicinal Chemistry, vol. 19, no. 32, pp. 5459–5466, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. R. Shibata, K. Sato, D. R. Pimentel et al., “Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2-dependent mechanisms,” Nature Medicine, vol. 11, no. 10, pp. 1096–1103, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. K. Kondo, R. Shibata, K. Unno et al., “Impact of a single intracoronary administration of adiponectin on myocardial ischemia/reperfusion injury in a pig model,” Circulation: Cardiovascular Interventions, vol. 3, no. 2, pp. 166–173, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. R. Shibata, N. Ouchi, M. Ito et al., “Adiponectin-mediated modulation of hypertrophic signals in the heart,” Nature Medicine, vol. 10, no. 12, pp. 1384–1389, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Maruyama, R. Shibata, K. Ohashi et al., “Adiponectin ameliorates doxorubicin-induced cardiotoxicity through Akt protein-dependent mechanism,” Journal of Biological Chemistry, vol. 286, no. 37, pp. 32790–32800, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Liu, T. Yin, X. Wei et al., “Downregulation of adiponectin induced by tumor necrosis factor α is involved in the aggravation of posttraumatic myocardial ischemia/reperfusion injury,” Critical Care Medicine, vol. 39, no. 8, pp. 1935–1943, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. K. Drosatos, R. S. Khan, C. M. Trent et al., “Peroxisome proliferator-activated receptor-ã activation prevents sepsis-related cardiac dysfunction and mortality in mice,” Circulation: Heart Failure, vol. 6, no. 3, pp. 550–562, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. L. C. Casey, R. A. Balk, and R. C. Bone, “Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome,” Annals of Internal Medicine, vol. 119, no. 8, pp. 771–778, 1993. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Sun, F. Dawood, W. Wen et al., “Excessive tumor necrosis factor activation after infarction contributes to susceptibility of myocardial rupture and left ventricular dysfunction,” Circulation, vol. 110, no. 20, pp. 3221–3228, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. T. Kadokami, C. Frye, B. Lemster, C. L. Wagner, A. M. Feldman, and C. F. McTiernan, “Anti-tumor necrosis factor-α antibody limits heart failure in a transgenic model,” Circulation, vol. 104, no. 10, pp. 1094–1097, 2001. View at Publisher · View at Google Scholar · View at Scopus
  27. T. Kubota, G. S. Bounoutas, M. Miyagishima et al., “Soluble tumor necrosis factor receptor abrogates myocardial inflammation but not hypertrophy in cytokine-induced cardiomyopathy,” Circulation, vol. 101, no. 21, pp. 2518–2525, 2000. View at Publisher · View at Google Scholar · View at Scopus
  28. T. Kadokami, C. F. McTiernan, T. Kubota et al., “Effects of soluble TNF receptor treatment on lipopolysaccharide-induced myocardial cytokine expression,” The American Journal of Physiology: Heart and Circulatory Physiology, vol. 280, no. 5, pp. H2281–H2291, 2001. View at Google Scholar · View at Scopus
  29. N. Ouchi, S. Kihara, Y. Arita et al., “Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages,” Circulation, vol. 103, no. 8, pp. 1057–1063, 2001. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Kumada, S. Kihara, N. Ouchi et al., “Adiponectin specifically increased tissue inhibitor of metalloproteinase-1 through interleukin-10 expression in human macrophages,” Circulation, vol. 109, no. 17, pp. 2046–2049, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Higuchi, K. Ohashi, S. Kihara, K. Walsh, and N. Ouchi, “Adiponectin suppresses pathological microvessel formation in retina through modulation of tumor necrosis factor-α expression,” Circulation Research, vol. 104, no. 9, pp. 1058–1065, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. V. Vachharajani, J. M. Russell, K. L. Scott et al., “Obesity exacerbates sepsis-induced inflammation and microvascular dysfunction in mouse brain,” Microcirculation, vol. 12, no. 2, pp. 183–194, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. G. Singer, K. Y. Stokes, S. Terao, and D. N. Granger, “Sepsis-induced intestinal microvascular and inflammatory responses in obese mice,” Shock, vol. 31, no. 3, pp. 275–279, 2009. View at Publisher · View at Google Scholar · View at Scopus